Cargando…

Impact of COVID-19 on chronic migraine treated with erenumab: a case report

BACKGROUND: Headache is a frequent symptom of the novel coronavirus 19 disease (COVID-19). To date, there are limited information on how COVID-19 affects migraine and its treatment. CASE DESCRIPTION: A 47-year-old patient, suffering from chronic migraine and medication-overuse headache, in September...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassini, Alberto, Marcinnò, Andrea, Roveta, Fausto, Gallo, Erica, Cermelli, Aurora, Boschi, Silvia, Rubino, Elisa, Rainero, Innocenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139216/ https://www.ncbi.nlm.nih.gov/pubmed/34021438 http://dx.doi.org/10.1007/s10072-021-05329-5

Ejemplares similares

Effects of COVID-19 on a migrainous patient treated with erenumab: A case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022)

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)

Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
por: Marcinnò, Andrea, et al.
Publicado: (2022)

Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study
por: Rubino, Elisa, et al.
Publicado: (2022)

Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?
por: Rubino, Elisa, et al.
Publicado: (2022)

A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report
por: Roveta, Fausto, et al.
Publicado: (2023)

Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
por: Roveta, Fausto, et al.
Publicado: (2021)

O057. Altered plasma adipokines concentrations in chronic migraine
por: Rubino, Elisa, et al.
Publicado: (2015)

How the COVID-19 emergency changed our modality to treat patients with migraine: a positive aspect of the pandemic
por: Grazzi, Licia, et al.
Publicado: (2022)

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report
por: Bozzali, Marco, et al.
Publicado: (2021)

Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine
por: Consonni, Monica, et al.
Publicado: (2020)

Sleep and sleep-modifying factors in chronic migraine patients during the COVID-19 lockdown
por: Currò, Carmelo Tiberio, et al.
Publicado: (2022)

Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes
por: Currò, Carmelo Tiberio, et al.
Publicado: (2021)

Management of chronic migraine with medication overuse by web-based behavioral program during the COVID-19 emergency: results at 12 months
por: Grazzi, Licia, et al.
Publicado: (2021)

Genetic variants in the NOTCH4 gene influence the clinical features of migraine
por: Rubino, Elisa, et al.
Publicado: (2013)

Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline
por: Botto, Rossana, et al.
Publicado: (2022)

Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy
por: Parodi, Italo Carlo, et al.
Publicado: (2020)

Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report
por: Arca, Karissa N., et al.
Publicado: (2020)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

The Carers’ Needs Assessment for Dementia (CNA-D): a validation study in the Italian population
por: Zucca, Milena, et al.
Publicado: (2021)

P055. Prevalence of migraine in subclinical hypothyroidism: a case-control study
por: Rainero, Innocenzo, et al.
Publicado: (2015)

Virtual visits for chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Post-COVID-19 airway stenosis treated by tracheal resection and anastomosis: a bicentric experience
por: Piazza, Cesare, et al.
Publicado: (2022)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Evidence for an association between migraine and the hypocretin receptor 1 gene
por: Rainero, Innocenzo, et al.
Publicado: (2011)

Early onset of efficacy with erenumab in patients with episodic and chronic migraine
por: Schwedt, Todd, et al.
Publicado: (2018)

Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
por: Manickam, Agaath Hedina, et al.
Publicado: (2021)

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis
por: Hada, Manila, et al.
Publicado: (2022)

SARS-CoV2 Related Multi System Inflammatory Syndrome in a Child with Chronic Kidney Disease: Case Report
por: Stefanachi, Francesca, et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Assessment and characteristics of Erenumab therapy on migraine management
por: Saeed, Haitham, et al.
Publicado: (2022)

Palliative Care in the Time of COVID-19
por: Mercadante, Sebastiano, et al.
Publicado: (2020)

Vascular Surgeon Discomfort in a Pandemic Setting
por: Settembrini, Alberto M., et al.
Publicado: (2020)

Treating COVID-19 patients with EMDR: A pilot study
por: Brennstuhl, Marie-Jo, et al.
Publicado: (2022)

Results of COVID-19 screening in a dermatologic clinic in Northern Italy
por: BURLANDO, MARTINA, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gvvbb4rcfoepscvh56pihj39g